MimiVax
MimiVax is a privately-held, clinical-stage biotechnology company that focuses on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. Its vaccines use survivin-targeting technology to target a cell-survival protein present in most cancers that enable healthcare providers to cure their patients. The company was founded in 2012 and is headquartered in Buffalo, New York.
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does MimiVax use?+
MimiVax uses 24 technologies including Elementor, Font Awesome, OceanWP.
What industry is MimiVax in?+
MimiVax operates in the Biopharma industry.
Where is MimiVax based?+
MimiVax is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026